Disambiguation evidence for idarucizumab via surface form
"idarucizumab"
Triples (3)
Triples where some other subject referred to this entity
as "idarucizumab".
Disambiguation evidence for idarucizumab via surface form
Triples where some other subject referred to this entity
as "idarucizumab".